chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness, swelling, and warmth at injection site. Left deltoid - "more than normal"
Patient developed mild convulsion mostly in upper left extremity especially in wrist and hands, lasting 2-3 minutes.  Patient remained conscious throughout the episode.  Recovered without complication and left office in stable condition.
3/19/13 - Tdap administered at same time as depo-medrol shot (different arms). Also completing round of doxycycline mono, 100 mg, for mild respiratory infection. 3/23/13 - Woke up to severe, throbbing pain in shoulder blade, from shoulder to hand on same side of Tdap injection. Some numbness & pins n' needles ensued. Mobility very limited. Prescribed 3 day course of prednisone, 20 mg each, 60 mgs per day. Some initial relief then no effect. Oxycodon, hydrocodon & Advil also taken at prescribed intervals. Some short term relief experienced; not long lasting.
second dose, she does not know how it is remotely possible that a 1 inch or 1.5 inch needle could have gone in to the deltoid; experienced a "lot of pain and extreme tenderness" on the shoulder, tight were her arm connects to her shoulder; injection site turned red with a raised area; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6201; Expiration Date: 28Feb2021) via subcutaneous route of administration, administered in Arm on 24Feb2021 (at the age of 66 years old) as dose 2, single for COVID-19 immunisation; paracetamol (TYLENOL), route of administration, start and stop date, batch/lot number and dose were not reported for back pain. Medical history included autoimmune disorder (She added she has an autoimmune disease, lung problem and several of other comorbidities), lung problem, heavy/50 lbs over weight/I weigh 150 something pounds, soft tissue problems, and back aches. The patient's concomitant medications were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9269) via unspecified route of administration on 03Feb2021 09:30 (at the age of 66 years old) as single for COVID-19 immunisation and experienced as first dose, vaccine possibly left out of refrigeration. The patient experienced as, second dose, she does not know how it is remotely possible that a 1 inch or 1.5 inch needle could have gone in to the deltoid on 24Feb2021, experienced a "lot of pain and extreme tenderness" on the shoulder, tight were her arm connects to her shoulder, injection site turned red with a raised area on 2021. Reported as, She explained 8-10h prior to the receipt of her first dose of the Pfizer-BioNTech COVID-19 vaccine, she took a Tylenol for the back aches. She elaborated the reasons for believing she received the second dose subcutaneously. She explained the nurse took her free hand and gather all the tissue and administered the vaccine an inch for being on the shoulder. She said she doesn't know of a needle that can be that long and has never received a vaccine that high. She reported a "small quarter sized" "local reaction where the injection was administered". She also mentioned she experienced a "lot of pain and extreme tenderness " on the shoulder, tight were her arm connects to her shoulder. The patient underwent lab tests and procedures which included weight: 50 lbs on an unspecified date (50 lbs over weight), weight: weigh 150 something pounds on an unspecified date (weigh 150 something pounds). Outcome of all the events were unknown.  No follow-up attempts are possible. No further information is expected.
Sore injection site; Headache; Extreme fatigue; All over body aches; change in body scent; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6204) via an unspecified route of administration in the arm left on 18Mar2021 at 09:45 as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease, hypertension and lung disease (hypersensitivity lung disease). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medications(unspecified) within two weeks prior to the vaccination. On 20Mar2021 the patient experienced sore injection site, headache, extreme fatigue, all over body aches and change in body scent. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event's sore injection site, headache, extreme fatigue, all over body aches and change in body scent was recovered on unknown date of 2021.    No follow-up attempts are needed. No further information is expected.
I had, had three small bug bites on left leg on that I iced and went to bed. When I awoke the next morning, they were very large, they had swollen to the size of a 1-inch index card. I took the day off from work to go to the Urgent Care. I go a six-day course of steroids, as of today you can hardly see them.
This spontaneous report as received from a son's patient (physician) refers to his father of unknown age. Medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiry date were not reported). There was no concomitant medication provided. On an unknown date (two years after received ZOSTAVAX), the patient got shingles (herpes zoster). The patient sought medical attention. The outcome of herpes zoster was reported as recovered (unspecified date). The relatedness between the event above mentioned and ZOSTAVAX was not provided. Additional information is not expected because the reporter did not want to be contacted.
Arm hurt from shoulder to wrist; Headache; Diarrhea; Loss of appetite; Chest pain; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Oct2021 at 11:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included hydrochlorothiazide, losartan (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 19:00 (at the age of 51-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 19:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 31Oct2021 at 12:00, the patients arm hurt from shoulder to wrist, she had headache, diarrhea, loss of appetite, chest pain and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm hurt from shoulder to wrist, headache, diarrhea, loss of appetite, chest pain and tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient came to ED with chest pain.  Patient admitted to hospital with pulmonary emboli and Covid pneumonia.  Patient treated with remdesivir.
Diagnoses with costochondritis, treated with two courses of steroids, symptoms resolved within 4 weeks.
Patient received Tdap booster in AM. Patient reports of acute, sudden onset of nausea, headache and neck spasm. Denies blurred vision, slurred speech, SOB, chest pain. Vitals: BP 108/75, P 78, RR 16. Pt was in offsite clinic at the time of immunization. Clinic activate EMS and pt was transferred to local ER for precaution. Pt recovered.
Patient received DTap on 4/23 - on 4/24 Left deltoid became red Edematous + warm to touch, Ice packs were applied with good relief.
Extra dose administered; wasn't feeling good; it was really awful/felt so terrible all over/Her head was fuzzy.; couldn't function/still felt that she could hardly get around; having ill; they said this is probably a reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (wasn't feeling good), FEELING ABNORMAL (it was really awful/felt so terrible all over/Her head was fuzzy.), IMPAIRED WORK ABILITY (couldn't function/still felt that she could hardly get around), ILLNESS (having ill) and VACCINATION COMPLICATION (they said this is probably a reaction to the vaccine) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 046B21A and 006BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer (She received cancer treatment prior to vaccination.). Concomitant products included PANCREATIN (CREON) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced MALAISE (wasn't feeling good), FEELING ABNORMAL (it was really awful/felt so terrible all over/Her head was fuzzy.), IMPAIRED WORK ABILITY (couldn't function/still felt that she could hardly get around), ILLNESS (having ill) and VACCINATION COMPLICATION (they said this is probably a reaction to the vaccine). On 23-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (Extra dose administered). On 23-Aug-2021, EXTRA DOSE ADMINISTERED (Extra dose administered) had resolved. At the time of the report, MALAISE (wasn't feeling good), FEELING ABNORMAL (it was really awful/felt so terrible all over/Her head was fuzzy.), IMPAIRED WORK ABILITY (couldn't function/still felt that she could hardly get around), ILLNESS (having ill) and VACCINATION COMPLICATION (they said this is probably a reaction to the vaccine) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         Patients reported that no treatment medications were received.
hives over entire body. Temp 100.9. Treatment Benadryl every 5-6 hours.
This spontaneous report was received from a certified medical assistant (CMA) and refers to two patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapy were not reported. On an unknown date, the patients were vaccinated with improperly stored VARIVAX (lot # M032495, expiry date: 06-JUL-2018). Temperature excursion was over 14 degree of Fahrenheit and under 46 degree of Fahrenheit during 8 hours and 30 minutes. There was no previous temperature excursion. Data logger was involved. No adverse effect was reported.  Additional information has been requested.
Pt became dizzy and diaphoretic approximately 5 minutes after vaccination. She sat down and began to feel better. She reports fear of needles and not eating since 12pm that day. Approximately 10 minutes later she lost consciousness for approximately 30 seconds. Pt came to was given orange juice and left with her father around 20 minutes after vaccination.
Transient Ischemic Attack accute CVA Stroke caused from blood clot to bottom left of the cerebellum.
Arm sore on 01/13/2021 four spots that grew into one big spot she saw her doctor a week later.  Swelling and Pain
I have not had a period since receiving g my vaccine.  I was having regular periods until them. Had Myast in early April before vaccine.  Nothing  In May June or July
arm was sore after receiving the Covid-19 Vaccine; This is a spontaneous report from a contactable consumer. A 60-years-old male consumer (patient) reported for himself that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6203; NDC number and expiry date were reported as unknown) via an unspecified route of administration on 09Mar2021 in left arm as a single dose for covid-19 immunization. Medical history, other products, investigation assessment and concomitant medications were not reported. On 10Mar2021, in the morning the patient reported that his arm was a little sore after receiving the Covid-19 Vaccine. He received the vaccine in his left arm, and he was left-handed. He also received a flu shot. The patient does not have the physician email address or address to provide, and he was going for a physical tomorrow. He stated that his aunt (96-years-old) got the first dose of vaccine a couple of weeks ago and also got the second dose. She was fine and her arm was not even sore like his arm. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Chills, flu symptoms, skin aches, headache, neckpain, no fever but shaking chills, sore arm.
Baby's right leg became swollen and red; ankle was "purple". Leg went into "spasms". Baby was screaming and couldn't be consoled. Treated with cold wash cloth and Tylenol. Symptoms recurred at 22:00 the same day.
On Tuesday morning I developed conjunctivitis in both eyes, confirmed by a visit to urgent care. By Tuesday night, my left arm began to swell along with lymph node in arm pit. My arm turned red from an inch above the injection site to my elbow. The redness stretched around my arm and down my veins. By Thursday morning the pain was intense and the swelling and redness worse. I cannot rest my arm at my side. The Dr. said the injection was given incorrectly. It should have been two fingers down from my shoulder and given into my muscle. It was given 6 inches down from my should instead and likely hit a vein. I am now on 4 different medications for all of these side effects due to incorrect injection. I also was told to self monitor for blood clots.
Patient received injection on 07/03/2001. pt has a fever on 07/04/2001 of 100.9. He started with a rash on chest and back. Today 07/15/2001 rash in also on arms and face
This case was reported by a pharmacist and described the occurrence of neuropathy in a 54-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included allergy to NSAID and seasonal allergic rhinitis. There were no concurrent medications. On 19 November 2007 at 12:00 the subject received a dose of FLULAVAL in the left arm. On the evening of 19 November 2007, less than one day after vaccination with FLULAVAL, the subject developed mild inflammation at the injection site. Later, on 20 November 2007, the subject developed an achy feeling, soreness in rib case, numbness from the mid-chest downward, loss of tactile sensation from the waist down, a slight tingling in the extremities (fingers and toes), an inability to urinate for about 8 to 10 hours, impotence and pain in the shoulder and scapula bilaterally (more severe on left injection side). The subject's body temperature was normal. The next day, on 21 November 2007, the subject experienced right leg weakness (leg gave way while walking downstairs). His body temperature was still normal. On 22 November 2007, the subject continued to experience weakness and severe dizziness was noted. The subject was unable to drive a car. Right leg weakness continued (leg gave way while walking downstairs for the second time). On 25 November 2007, impotence resolved, but shoulder, rib and chest soreness continued. The subject's body temperature was normal. The next day, on 26 November 2007, urination was better, but it was still difficult to start urine flow. There was suspected prostate involvement. The subject was started on Bactrim DS twice daily for 21 days. On 05 December 2007, general weakness was improving and mild dizziness continued. On 12 December 2007, acute symptoms resolved, mild dizziness, generalized muscle weakness and tenderness persisted. On 13 December 2007, the subject met with a urologist and he was diagnosed with transient neuropathy, probably related to the flu shot. It was described like Guillain-Barre Syndrome. The pharmacist considered the events were clinically significant (or requiring intervention). As of 15 June 2008, general muscle weakness and tenderness persisted, especially around the upper body. As of 11 September 2008, muscle tenderness persisted throughout the upper body, but the subjects legs were okay. The reporter stated that the following had resolved: muscle tenderness and generalized upper body soreness. The reporter felt that causality of the events to FLULAVAL was probable.
Rash on back, 10 to 15 small erythematous papules on back most crusted, a few vesicles, 10/11/2001. Medication: Benadryl  by mouth as occasion requires return to clinic if rash increases.
Snycopal episode at 10 am, just over 24 hours after administration with approximate 10 second loss of consciousness.  Lightheaded much of the second day, connected to orthostatic hypotension.   Fluids and rest.
vaccine aggravated the injury and caused the bruise.; she started getting a bruise on her left arm which swelled and was sore; Swelling in her arm; Soreness in her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swelling in her arm), PAIN IN EXTREMITY (Soreness in her arm), CONTUSION (she started getting a bruise on her left arm which swelled and was sore) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Shoulder injury (One year back) in 2020.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in her arm) and PAIN IN EXTREMITY (Soreness in her arm). On 17-Mar-2021, the patient experienced CONTUSION (she started getting a bruise on her left arm which swelled and was sore). On an unknown date, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.). On 12-Mar-2021, PERIPHERAL SWELLING (Swelling in her arm) had resolved, PAIN IN EXTREMITY (Soreness in her arm) outcome was unknown. At the time of the report, CONTUSION (she started getting a bruise on her left arm which swelled and was sore) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter. Patient had two therapy appointment between the first dose and the bruise appearing. Treatment medication include the  Ice on that area.
Pulled out an expired medication. Medication was drawn up on 1/13 and is only good for 12 hours. Vaccine was then given on 1/16/23.
- Arm pain (sore) 19 days - Rash/welt at injection site - Red
Swelling, redness, tenderness 3x3ccm 7x5 cm (R) upper arm. 1.5 x 1.5cm lump over (R) upper arm.
Received vaccine "ADACEL" on 11/15/15. Patient called the pharmacy on 11/25/15 stating she was aware that the vaccine would cause pain at the injection site, but has been 10 days and is sill in pain and experiencing numb/tingling sensation.
1. 1 hr post injection- itching at injection site lasting 2-3 hours. 2. 15 hr post injection- soreness, redness at 1 in. diameter. 3. 36 hr post injection- total arm soreness, axillary soreness, tightness in hand. Redness (dark) at 2" x 4" in diameter, fever at injection site with palpable knot in red area.  4. 60 hr post injection- Redness is splotchy, upper arm still sore, but less sore, fever at injection site., palpable knot still present. 5. 96 hr post injection- Redness subsided, injection site sore, fever subsided at site, palpable knot still present.
Patient sitting in waiting/observation area in wheelchair following vaccination. Approximately 20-30 min after vaccination, patient reported tingling in right hand/fingers. No pain or tingling on rest of arm or shooting down arm or around injection site, no difficulty moving arm. No itching or signs of allergic reaction. No other symptoms. Patient was evaluated by myself and a nurse. No change in status. Patient was advised to follow up with primary care doctor if persistent or worsening.
This spontaneous report was received from a registered nurse (who is the mother) refers to a 1 year 4 month old female patient. The patient had pertinent medical history of multiple ear infection and pneumonia. The patient has AMOXIL allergy. On 22-MAR-2007, the patient was vaccinated with a dose 1 of PNEUMOVAX 23 (manufacturer unknown) (also reported as PNEUMOVAX 7 and PNEUMOVAX 13 (lot number, expiration date and route not reported). The patient was vaccinated with PNEUMOVAX 23 (also reported as PNEUMOVAX 7) on 22-MAR-2007, 31-MAY-2007, 31-JUL-2007, 25-JAN-2008. She was also vaccinated with PNEUMOVAX 23 (manufacturer unknown) (also reported as PNEUMOVAX 13) (lot number, expiration date and route not reported) on 09/02/2010. No concomitant medications were reported. The patient did not develop immunity to either one of the vaccines. On an unknown date in May-2008, the reporter stated that the patient kept getting unspecified infections and was diagnosed with pneumonia where she was hospitalized from 10-NOV-2012 to 11-NOV-2012. It was unknown whether the product involved was PNEUMOVAX 23 or PREVNAR (other manufacturer) as the reporter referred to the vaccine as PNEUMOVAX 7 and PNEUMOVAX 13. Pneumococcal titers were performed and the result was unknown. There was no treatment rendered for the events. Outcome of the reported events were unknown. The patient sought medical attention. Additional information has been requested.
Third shot was Moderna.  First two were Pfizer, last pfizer injection was given in January 2021.  No side effects to first two.   Third moderna shot had 48 hours of fever, chills, severe headache.   1.5 to two days later developed 'covid arm':  swollen, hot, red, mildly itchy 6 inch area around injection site.  Improving on and off with otc cortizone cream with symptoms currently milder but continuing.